These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 11524994)

  • 21. Glitazones in type 2 diabetes: an update.
    Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.
    Rosenstock J; Einhorn D; Hershon K; Glazer NB; Yu S;
    Int J Clin Pract; 2002 May; 56(4):251-7. PubMed ID: 12074206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

  • 25. [Type 2 diabetes. Routine ACE inhibitors?].
    Hönl SB
    Med Monatsschr Pharm; 2008 Apr; 31(4):149-50. PubMed ID: 18497249
    [No Abstract]   [Full Text] [Related]  

  • 26. ARBs vs ACE inhibitors for preventing diabetic nephropathy.
    Greenwood V
    J Fam Pract; 2005 May; 54(5):453; discussion 453-4. PubMed ID: 15865904
    [No Abstract]   [Full Text] [Related]  

  • 27. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Weber MA
    Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glitazone in Parkinson's Disease.
    Amanat M; Salehi M
    Mov Disord; 2018 May; 33(5):856-857. PubMed ID: 29644720
    [No Abstract]   [Full Text] [Related]  

  • 29. [Primary prevention of diabetes mellitus by pharmacological intervention].
    Noda M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.
    Abuissa H; Jones PG; Marso SP; O'Keefe JH
    J Am Coll Cardiol; 2005 Sep; 46(5):821-6. PubMed ID: 16139131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of arteriosclerosis with the insulin sensitizer pioglitazone. Early intervention in diabetic patients compensates "cell ignorance"].
    MMW Fortschr Med; 2002 May; 144(21):52-3. PubMed ID: 12134427
    [No Abstract]   [Full Text] [Related]  

  • 32. [ACE inhibitor even prevents diabetes. Sensational HOPE Study].
    MMW Fortschr Med; 1999 Sep; 141(39):6. PubMed ID: 10897977
    [No Abstract]   [Full Text] [Related]  

  • 33. [ACE inhibitor plus glitazone. Insulin sensitizer, preventing diabetes?].
    MMW Fortschr Med; 2001 Jul; 143(30):52. PubMed ID: 11524994
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.